General
Preferred name
AZILSARTAN
Synonyms
TAK-536 ()
Azilsartan D5 ()
TAK-536 D5 ()
Azilsartan (TAK-536) ()
Azilsartan-d5 ()
P&D ID
PD010495
CAS
147403-03-0
1346599-45-8
Tags
available
drug
Drug indication
Hypertension
Drug Status
approved
investigational
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION The active form of the approved drug azilsartan medoxomil. (GtoPdb)
PRICE 29
DESCRIPTION Azilsartan (TAK-536) is an orally active, potent, selective and specific angiotensin II type 1 receptor (AT1) antagonist. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. Azilsartan can be used for hypertension and stroke research[1][2][3][4][5].
DESCRIPTION Azilsartan is an analgesic and antiinflammatory drugs containing angiotensin II antagonists. It is an active metabolite of azilsartan medoxomil. (Enamine Bioactive Compounds)
DESCRIPTION Potent and selective CGRP antagonist (Tocris Bioactive Compound Library)
DESCRIPTION Potent AT1 receptor inverse agonist; antihypertensive (Tocriscreen Plus)
DESCRIPTION Azilsartan (TAK-536) is an Angiotensin 2 Receptor Blocker that acts as an Angiotensin 2 Type 1 Receptor Antagonist, leading to a physiologic effect of decreased blood pressure. (TargetMol Bioactive Compound Library)
Compound Sets
20
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
External IDs
72
Properties
(calculated by RDKit )
Molecular Weight
456.14
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
7
Ring Count
5
Aromatic Ring Count
5
cLogP
4.19
TPSA
123.24
Fraction CSP3
0.12
Chiral centers
0.0
Largest ring
6.0
QED
0.38
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
Target
Angiotensin Receptor
AT1 receptor
AGTR1, AGTR2
AT1 antagonist
Reactive Oxygen Species (ROS)
Reactive Oxygen Species
Pathway
GPCR/G protein
Apoptosis
Immunology/Inflammation
Metabolic Enzyme/Protease
NF-κB
Endocrinology/Hormones
NF-¦ÊB
Primary Target
Angiotensin AT1 Receptors
MOA
Inverse Agonist
angiotensin receptor antagonist
Indication
hypertension
Source data